BioSpace News Archive

Press Releases

Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

May 12, 2025
·
14 min read
Press Releases

Sionna Therapeutics Reports First Quarter 2025 Financial Results

May 12, 2025
·
9 min read
Press Releases

Harvard Bioscience Announces First Quarter 2025 Financial Results

May 12, 2025
·
10 min read
Press Releases

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

May 12, 2025
·
5 min read
Press Releases

BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025
·
15 min read
Press Releases

AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting

May 12, 2025
·
2 min read
Press Releases

Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)

May 12, 2025
·
11 min read
Press Releases

Ensoma Announces FDA Clearance of IND Application for First In Vivo HSC-Directed Gene Insertion Therapy

May 12, 2025
·
4 min read
Press Releases

Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome

May 12, 2025
·
9 min read
Press Releases

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

May 12, 2025
·
6 min read